The Patent Finder

Terms ending in 2031

Phio Pharmaceuticals Corp.

Every in-force patent on Phio Pharmaceuticals Corp.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,300,027Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
In force
 · High confidence
Hapten Pharmaceuticals, LLCIn forceHigh confidence
US 9,340,786RNA Interference in Dermal and Fibrotic Indications
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 10,184,124RNA Interference in Ocular Indications
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In forceMedium confidence
US 10,240,149Reduced Size Self-Delivering Rnai Compounds
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 10,662,430RNA Interference in Ocular Indications
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 10,913,948RNA Interference in Dermal and Fibrotic Indications
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 11,118,178Reduced Size Self-Delivering Rnai Compounds
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 9,095,504RNA Interference in Ocular Indications
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
US 11,584,933RNA Interference in Ocular Indications
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In forceMedium confidence
US 9,080,171Reduced Size Self-Delivering Rnai Compounds
In force
 · High confidence
Phio Pharmaceuticals Corp.In forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
9 of these are in force and held by Phio Pharmaceuticals Corp..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited